The Valley Desk

ArticleMolecular therapy. Methods & clinical developmentPublished

Pre-existing immunity does not impair the engraftment of CRISPR-Cas9-edited cells in rhesus macaques conditioned with busulfan or radiation

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Children’s Hospital of Philadelphia. Affiliation source

Publication record

Type
Article
Venue
Molecular therapy. Methods & clinical development
Published
Subject terms
Gene therapy; Immunity; Hematopoietic stem cell transplantation; Genome Editing; Spcas9; Sacas9
PubMed ID
37273902
PubMed Central ID
PMC10236215
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal